Navigation Links
Cancer Patients Can Benefit From Early Detection Of Heart Damage Using Echocardiography
Date:10/6/2011

MORRISVILLE, N.C., Oct. 6, 2011 /PRNewswire-USNewswire/ -- There is good news for cancer patients whose medical treatments put them at risk for future cardiac problems: using strain echocardiography can help physicians detect early signs of cardiac toxicity.  To help get this information out to those in need, the American Society of Echocardiography (ASE) is preparing a guideline document outlining the best way to evaluate cancer patients, and has funded a research study to enhance identification of patients who are at risk.

The September 2011 death of 51-year-old Kara Kennedy of a heart attack brought the link between cancer treatments and cardiovascular damage into the spotlight for both patients and their physicians. Kennedy, the only daughter of Senator Edward M. Kennedy, was reportedly in remission after having been treated for lung cancer in 2002. While the direct relationship between her cancer treatment and her death remain unclear, one theory links damage to her heart from her chemo treatments.  With this tragedy, physician awareness of the link between specific cancer therapies and heart complications has renewed interest.

In the past, when cancer treatments were not very effective and cancer was usually fatal, little attention was paid to the complications from treatment.  With the advent of more successful new therapies for cancer that have raised survival rates, concerns about their long-term effects have now become paramount. "There are 2.2 million survivors of breast cancer in the U.S. alone," said Juan Carlos Plana, MD, Co-director of Cardio-oncology, Cleveland Clinic, "and heart disease, not cancer, is the biggest risk they face." When a patient is diagnosed with breast cancer, she (or he) is tested for the HER2 mutation, an aggressive form of cancer which affects 20-25% of breast cancer patients and is typically treated with Doxorubicin, followed by Herceptin. Unfortunately, as many as one third of patients receiving these two drugs will develop cardiotoxicity, and some will progress to full-blown heart failure, which means they could potentially need mechanical devices or heart transplants in order to survive.  

The advent of strain echocardiography for early identification of cardiac problems is great news for those suffering from many forms of cancer. "The goal is not to stop cancer therapy, but to identify cardiotoxicity early and to protect the heart with medications so heart failure does not become a problem and the cancer treatment can be continued," Dr. Plana explained. "Currently, 17% of patients receiving treatment for the most aggressive form of breast cancer have to stop therapy due to heart issues. The sensitivity of strain echo allows early detection so oncologists can treat their patients without fear of the downstream effects of the therapies."

Dr. Plana, who is a Fellow of the American Society of Echocardiography and served as medical director of cardiac imaging at Houston's MD Anderson Cancer Center, now heads a newly-formed cardio-oncology center at the Cleveland Clinic, where every patient slated for a cancer therapy with the potential for toxicity receives an intensive left-ventricular mechanics protocol, which includes both 3D echocardiography with contrast and strain imaging.

To highlight the benefits of these screenings, ASE has collaborated with the European Association of Echocardiography and the American Society of Clinical Oncology to organize a guideline writing group, led by Dr. Plana.  A previous paper  entitled "Early Detection and Prediction of Cardiotoxicity in Chemotherapy-Treated Patients," written with ASE Board of Directors member Marielle Scherrer-Crosbie, MD, PhD, FASE, MCH, Associate Professor of Medicine, Massachusetts General Hospital and Harvard Medical School, and others for the American Journal of Cardiology, has already outlined exciting progress in this area.

ASE expects its new guideline to be available in 2012. To take the new clinical application for echocardiography one step further, the ASE Education and Research Foundation has also funded a Career Development Award on the use of strain and 3D echocardiography to identify patients who are at high risk for developing heart complications even before they start chemotherapy treatment. The lead researcher, ASE member Timothy Tan, MBBS, PhD, Clinical and Research Fellow, Massachusetts General Hospital and Harvard Medical School, hopes the research "will increase the understanding of heart failure associated with cancer treatment, potentially helping to decrease its morbidity and mortality."

As the largest global organization for cardiovascular ultrasound imaging, the American Society of Echocardiography (ASE) is the leader and advocate, setting practice standards and guidelines.  Comprised of over 15,000 physicians, sonographers, nurses and scientists, ASE is a strong voice providing guidance, expertise and education to its members with a commitment to improving the practice of ultrasound and imaging of the heart and cardiovascular system for better patient outcomes. Full text of ASE's guidelines is available at http://www.asecho.org/guidelines.  For more information about ASE, visit www.asecho.org or ASE's public information site, www.SeeMyHeart.org.

CONTACT:
Cathy Kerr (919) 297-7156
ckerr@asecho.org or
Andrea Van Hoever (919) 297-7163
avanhoever@asecho.org


'/>"/>
SOURCE American Society of Echocardiography
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. Novel Technology Breaks Through Cancer Pain
8. CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug
9. Furamidine Found to Inhibit a Key Enzyme Involved in Cancer Cell DNA Repair Mechanisms
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... June 26, 2016 Story ... operating models within the health care industry is causing ... efficiency , Deloitte offers a suite of solutions ... issues impacting efficient cost optimization: labor resource analysis, revenue ... services facilitate better outcomes and better economics ...
(Date:6/24/2016)... 24, 2016 ... the addition of the " Global Markets for ... This report focuses on ... updated review, including its applications in various applications. The ... which includes three main industries: pharmaceutical and biotechnology, food ...
(Date:6/24/2016)... Research and Markets has announced the addition of the ... to their offering. ... World Market for Companion Diagnostics covers the world market for ... report includes the following: , World IVD ... (N. America, EU, ROW), 2015-2020 , World IVD Companion ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... announced its strategic partnership with Connance, a healthcare industry leader providing predictive ... proven, proprietary technology combine to provide health systems, hospitals and ambulatory surgical ...
(Date:6/26/2016)... ... 27, 2016 , ... Quality metrics are proliferating in cancer care, and are ... the eye of the beholder, according to experts who offered insights and commentary in ... Managed Care. For the full issue, click here . , For the American ...
(Date:6/26/2016)... Cary, North Carolina (PRWEB) , ... June 26, 2016 , ... ... the release of a new product that was developed to enhance the health of ... harvested for centuries. , The two main herbs in the PawPaws Cat Kidney ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American Institutes ... Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , ... advance care planning, healthcare costs and patient and family engagement. , AIR researchers ...
(Date:6/25/2016)... Aliso Viejo, California (PRWEB) , ... June 25, 2016 , ... ... preset to fit their specific project," said Christina Austin - CEO of Pixel Film ... all fully customizable and all within Final Cut Pro X . Simply select ...
Breaking Medicine News(10 mins):